QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.108.137208v1 326/2/369    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masood, A. Articles by O'Donnell, J. M. Search for Related Content PubMed PubMed Citation Articles by Masood, A. Articles by O'Donnell, J. M.

NEUROPHARMACOLOGY

Reversal of Oxidative Stress-Induced Anxiety by Inhibition of Phosphodiesterase-2 in Mice

Departments of Behavioral Medicine and Psychiatry and Neurobiology and Anatomy (A.M., J.M.O.) and Physiology and Pharmacology (A.N., S.J.M.), West Virginia University Health Sciences Center, Morgantown, West Virginia

The pathogenesis of several neuropsychiatric disorders, including anxiety and depression, has been linked to oxidative stress, in part via alterations in cyclic nucleotide signaling. Phosphodiesterase-2 (PDE2), which regulates cGMP and cAMP signaling, may affect anxiety-related behavior through reduction of oxidative stress. The present study evaluated the effects of oxidative stress on behavior and assessed the anxiolytic effects of the PDE2 inhibitor Bay 60-7550 [(2-(3,4-dimethoxybenzyl)-7-{(1R)-1-[(1R)-1-hydroxyethyl]-4-phenylbutyl}-5-methyl imidazo-[5,1-f][1,2,4]triazin-4(3H)-one)]. Treatment of mice with L-buthionine-(S,R)-sulfoximine (300 mg/kg), an inducer of oxidative stress, caused anxiety-like behavioral effects in elevated plusmaze, open-field, and hole-board tests through the NADPH oxidase pathway; these effects were antagonized by Bay 60-7550 (3 mg/kg) and apocynin (3 mg/kg), an inhibitor of NADPH oxidase. The Bay 60-7550-mediated decrease in oxidative stress (i.e., superoxide anion and reactive oxygen species generation in cultured neurons and total antioxidant capacity and lipid peroxides in amygdala and hypothalamus) and expression of NADPH oxidase subunits (i.e., p47 phox and gp91 phox expression in amygdala, hypothalamus, and cultured neurons) was associated with increased cGMP and phosphorylation of vasodilator-stimulated phosphoprotein at Ser239, suggesting an important role of cGMP-protein kinase G signaling in reduction of anxiety. Overall, the present results indicate that oxidative stress induces anxiety-like behavior in mice and that PDE2 inhibition reverses it through an increase in cGMP signaling. Thus, PDE2 may be a novel pharmacological target for treatment of anxiety in neuropsychiatric and neurodegenerative disorders that involve oxidative stress.

Address correspondence to: Dr. Anbrin Masood, West Virginia University, P.O. Box 9128, Morgantown, WV 26506. E-mail: amasood{at}hsc.wvu.edu

This article has been cited by other articles:

				A. Masood, Y. Huang, H. Hajjhussein, L. Xiao, H. Li, W. Wang, A. Hamza, C.-G. Zhan, and J. M. O'Donnell Anxiolytic Effects of Phosphodiesterase-2 Inhibitors Associated with Increased cGMP Signaling J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 690 - 699. [Abstract] [Full Text] [PDF]

				C. Favilla, T. Abel, and M. P. Kelly Chronic G{alpha}s Signaling in the Striatum Increases Anxiety-Related Behaviors Independent of Developmental Effects J. Neurosci., December 17, 2008; 28(51): 13952 - 13956. [Abstract] [Full Text] [PDF]